Abstract
The effect of ultrasound (US) on permeation of two model drugs, caffeine (CAF) and morphine (MOR), through hairless mouse skin in vitro was compared with that of three chemical enhancers. Low-frequency (40 KHz), low-power (<0.5 W/cm(2)) US was used; the effect of high-frequency US (1.5-3.0 MHz) was also evaluated in the case of CAF. The chemical enhancers, tested in combination with propylene glycol (PG), were benzalkonium chloride (BAC) oleyl alcohol (OA) and alpha-terpineol (TER). The high-frequency US enhancement of CAF transdermal flux was not statistically significant, while low frequency produced a small but significant increase of the enhancement factor. The effect of US on CAF permeation, however, was lower than that produced by chemical enhancers, in particular OA. The effect of low-frequency US on permeation of MOR was significantly greater (about 10-fold) when compared, on the same frequency and intensity basis, with the effect on CAF. The most active chemical enhancer for MOR, OA, had practically the same effect as low-frequency US. Sonicated skin, although showing slight histological changes, recovered its original low permeability characteristics after turning off sonication. Within the tested system, chemical enh...Continue Reading
References
Jan 1, 1992·Journal of Pain and Symptom Management·M A AshburnA A Hofman
Jan 1, 1989·Selective Cancer Therapeutics·K SugibayashiY Morimoto
Jun 1, 1995·Journal of Pharmaceutical Sciences·S MitragotriR Langer
Jan 1, 1993·Journal of Biomaterials Science. Polymer Edition·M Machluf, J Kost
Oct 9, 1999·Journal of Pharmaceutical Sciences·B C Finnin, T M Morgan
Nov 11, 1999·International Journal of Pharmaceutics·J FangH Chen
Citations
Mar 6, 2007·Lasers in Medical Science·Woan-Ruoh LeeJia-You Fang
Aug 1, 2013·Ultrasonics·Donghee ParkSeunghun Lee
Sep 11, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amit Joshi, Jaideep Raje
Aug 15, 2002·International Journal of Pharmaceutics·L Machet, A Boucaud
Apr 17, 2004·Skin Pharmacology and Physiology·S NicoliP Santi
Sep 9, 2005·The AAPS Journal·Sara NicoliPatrizia Santi
Jan 18, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Baris E PolatDaniel Blankschtein
May 19, 2009·International Journal of Pharmaceutics·Lucie DuracherGilberte Marti-Mestres
Nov 27, 2009·The Journal of Investigative Dermatology·Sang Eun LeeSeung Hun Lee
Jan 2, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ilana LavonGiora Enden
Jun 10, 2009·The Journal of Pharmacy and Pharmacology·Rekha Rao, Sanju Nanda
Jul 29, 2004·Drug Discovery Today·Ilana Lavon, Joseph Kost
Mar 6, 2004·Pharmaceutical Development and Technology·Dimitrios A DimasDimitrios M Rekkas
Apr 7, 2016·Pharmaceutical Development and Technology·R M BarbosaM H A Santana
Sep 22, 2007·The Journal of Pharmacy and Pharmacology·Kevin B ItaJeanetta du Plessis
Jul 10, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Franklin K AkomeahMarc B Brown
Sep 17, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ilana LavonJoseph Kost
Oct 13, 2011·The Journal of Pharmacy and Pharmacology·Gary P MossMarc B Brown
Aug 20, 2017·Lasers in Medical Science·J H ChoiM K Shin
Aug 14, 2019·Drug Delivery and Translational Research·Shupeng LiuNa Chen
Jul 10, 2021·International Journal of Pharmaceutics·Jungen ChenLifeng Kang